Dante Labs Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
85
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
6
- Investments
-
2
Dante Labs General Information
Description
Developer of a sequencing technology designed to make advanced genomic testing accessible to everyone. The company offers whole genome sequencing, whole exome sequencing, and genetic testing services along with data analysis and interpretation, thereby enabling users to access and understand their genetic information.
Contact Information
Website
www.dantelabs.com(Operating Subsidiary)
Corporate Office
- 667 Madison Avenue
- 5th Floor
- New York, NY 10065
- United States
Corporate Office
- 667 Madison Avenue
- 5th Floor
- New York, NY 10065
- United States
Dante Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dante Labs Comparisons
Industry
Financing
Details
Dante Labs Competitors (8)
One of Dante Labs’s 8 competitors is Gene By Gene, a Formerly VC-backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gene By Gene | Formerly VC-backed | Houston, TX | ||||
| Helix (Laboratory Services (Healthcare)) | Venture Capital-Backed | San Mateo, CA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| GeneDx Holding | Formerly VC-backed | Stamford, CT |
Dante Labs Patents
Dante Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202309975-D0 | Environmental simulation chamber | Inactive | 30-Jun-2023 | ||
| EP-4288536-A1 | Small interfering rna (sirna) for therapy of mmihs caused by actg2 gene mutation | Inactive | 05-Feb-2021 | ||
| WO-2022167877-A1 | Small interfering rna (sirna) for therapy of mmihs caused by actg2 gene mutation | Inactive | 05-Feb-2021 | C12N15/113 |
Dante Labs Signals
Dante Labs Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Dante Labs Investments & Acquisitions (2)
Dante Labs’s most recent deal was a Corporate Asset Purchase with Dante Labs (Lighthouse Lab). The deal was made on 26-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dante Labs (Lighthouse Lab) | 26-Jul-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Cambridge Cancer Genomics | 23-Jun-2021 | Merger/Acquisition | Decision/Risk Analysis |
Dante Labs FAQs
-
When was Dante Labs founded?
Dante Labs was founded in 2016.
-
Where is Dante Labs headquartered?
Dante Labs is headquartered in New York, NY.
-
What is the size of Dante Labs?
Dante Labs has 85 total employees.
-
What industry is Dante Labs in?
Dante Labs’s primary industry is Laboratory Services (Healthcare).
-
Is Dante Labs a private or public company?
Dante Labs is a Private company.
-
What is Dante Labs’s current revenue?
The current revenue for Dante Labs is .
-
How much funding has Dante Labs raised over time?
Dante Labs has raised $1.5M.
-
Who are Dante Labs’s investors?
Ben Jen Holdings has invested in Dante Labs.
-
Who are Dante Labs’s competitors?
Gene By Gene, Helix (Laboratory Services (Healthcare)), Illumina, Ambry Genetics, and GeneDx Holding are some of the 8 competitors of Dante Labs.
-
When was Dante Labs acquired?
Dante Labs was acquired on 01-Apr-2026.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process